一位39岁的女性患有高胆固醇血清症
1Harvard Medical School, Boston, Mass, USA. mmittlem@bidmc.harvard.edu
JAMA
|July 20, 2006
概括
本案例研究检查了一名39岁的非裔美国女性,患有高胆固醇和家族中风病史. 它讨论了她的冠心病 (CHD) 风险和降脂治疗选择.
科学领域:
- 心脏病学 心脏病学
- 预防医学 预防医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 一名39岁的非裔美国妇女呈现高胆固醇血症 (总胆固醇277毫克/分升) 和受控的高血压.
- 她有一个令人担忧的家族史,包括一个在30多岁时遭受中风的兄弟和患有乳腺癌的母亲.
研究的目的:
- 评估患者的10年和更长期冠心病 (CHD) 风险.
- 评估各种降脂疗法的证据,包括食补充剂和药物.
- 为风险管理和治疗坚持提供个性化的建议.
主要方法:
- 利用弗雷明汉风险评分来估计10年的心血管疾病风险.
- 考虑了患者特定的因素,如种族和家族病史,这些因素可能会影响风险评估.
- 审查了关于降脂干预措施的有效性和必要性的现有证据.
主要成果:
- 估计的10年心脏病风险很低 (1-2%),但这可能低估了她的实际风险.
- 考虑了降胆固醇药物的需要与食补充剂相比.
- 讨论了治疗坚持和生活方式改变的长期影响.
结论:
- 尽管计算风险低,但她的独特形象要求仔细考虑预防策略.
- 可能需要个性化降脂疗法,可能包括药物治疗.
- 长期坚持治疗和饮食是控制心血管风险的关键.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Lipids: Dietary Sources and Requirements
2.5K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.5K
Cholesterol: Significance and Regulation
2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.1K
Angina IV: Management
496
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
496
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747


